1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Qin, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be published
0353
Structural, dynamics, and RNA binding comparison between RBM10-RRM2 domain and its lung cancer related mutation.
10.2210/pdb5zsy/pdb
pdb_00005zsy
9577.053
RNA-binding protein 10
RBM10 RRM2 domain
1
man
polymer
G patch domain-containing protein 9,RNA-binding motif protein 10,RNA-binding protein S1-1,S1-1
no
no
GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTI
NVEFAKGS
GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTI
NVEFAKGS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Human
sample
1
88
RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122
9606
Homo sapiens
562
Escherichia coli
Biological sequence
database_2
pdbx_database_status
pdbx_nmr_spectrometer
repository
Initial release
Data collection
Database references
Other
1
0
2019-06-12
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_spectrometer.model
RBM10-RRM2 domain and its lung cancer related mutant
N
PDBJ
Y
PDBJ
2018-04-30
REL
REL
REL
REL
Sequence of the protein is based on isoform 4 of database P98175 (RBM10_HUMAN).
structures with the lowest energy
40
20
isotropic
1
4D APSY-HACANH
isotropic
1
5D APSY-CBCACONH
isotropic
1
5D APSY-HACACONH
isotropic
2
3D 1H-15N NOESY
isotropic
2
3D 1H-13C NOESY aliphatic
isotropic
2
3D 1H-13C NOESY aromatic
1.0
mM
[U-100% 13C; U-100% 15N]
20mM sodium Phosphate, 50mM sodium chloride
20mM sodium Phosphate, 50mM sodium chloride
mM
condition_1
6.5
pH
1
Pa
298
K
molecular dynamics
1
lowest energy
1.0 mM [U-100% 13C; U-100% 15N] RBM10 RRM2[V354del], 90% H2O/10% D2O
15N_13C_sample
90% H2O/10% D2O
solution
Volk, J.; Herrmann, T.; Fiorito, F.; Wuthrich, K.
chemical shift assignment
UNIO-ASCAN
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
Luginbuhl, Guntert, Billeter and Wuthrich
refinement
OPAL
600
Bruker
AVANCE
800
Bruker
AVANCE
GLY
1
n
1
GLY
1
A
HIS
2
n
2
HIS
2
A
MET
3
n
3
MET
3
A
ASP
4
n
4
ASP
4
A
THR
5
n
5
THR
5
A
ILE
6
n
6
ILE
6
A
ILE
7
n
7
ILE
7
A
LEU
8
n
8
LEU
8
A
ARG
9
n
9
ARG
9
A
ASN
10
n
10
ASN
10
A
LEU
11
n
11
LEU
11
A
ASN
12
n
12
ASN
12
A
PRO
13
n
13
PRO
13
A
HIS
14
n
14
HIS
14
A
SER
15
n
15
SER
15
A
THR
16
n
16
THR
16
A
MET
17
n
17
MET
17
A
ASP
18
n
18
ASP
18
A
SER
19
n
19
SER
19
A
ILE
20
n
20
ILE
20
A
LEU
21
n
21
LEU
21
A
GLY
22
n
22
GLY
22
A
ALA
23
n
23
ALA
23
A
LEU
24
n
24
LEU
24
A
ALA
25
n
25
ALA
25
A
PRO
26
n
26
PRO
26
A
TYR
27
n
27
TYR
27
A
ALA
28
n
28
ALA
28
A
VAL
29
n
29
VAL
29
A
LEU
30
n
30
LEU
30
A
SER
31
n
31
SER
31
A
SER
32
n
32
SER
32
A
SER
33
n
33
SER
33
A
ASN
34
n
34
ASN
34
A
VAL
35
n
35
VAL
35
A
ARG
36
n
36
ARG
36
A
VAL
37
n
37
VAL
37
A
ILE
38
n
38
ILE
38
A
LYS
39
n
39
LYS
39
A
ASP
40
n
40
ASP
40
A
LYS
41
n
41
LYS
41
A
GLN
42
n
42
GLN
42
A
THR
43
n
43
THR
43
A
GLN
44
n
44
GLN
44
A
LEU
45
n
45
LEU
45
A
ASN
46
n
46
ASN
46
A
ARG
47
n
47
ARG
47
A
GLY
48
n
48
GLY
48
A
PHE
49
n
49
PHE
49
A
ALA
50
n
50
ALA
50
A
PHE
51
n
51
PHE
51
A
ILE
52
n
52
ILE
52
A
GLN
53
n
53
GLN
53
A
LEU
54
n
54
LEU
54
A
SER
55
n
55
SER
55
A
THR
56
n
56
THR
56
A
ILE
57
n
57
ILE
57
A
GLU
58
n
58
GLU
58
A
ALA
59
n
59
ALA
59
A
ALA
60
n
60
ALA
60
A
GLN
61
n
61
GLN
61
A
LEU
62
n
62
LEU
62
A
LEU
63
n
63
LEU
63
A
GLN
64
n
64
GLN
64
A
ILE
65
n
65
ILE
65
A
LEU
66
n
66
LEU
66
A
GLN
67
n
67
GLN
67
A
ALA
68
n
68
ALA
68
A
LEU
69
n
69
LEU
69
A
HIS
70
n
70
HIS
70
A
PRO
71
n
71
PRO
71
A
PRO
72
n
72
PRO
72
A
LEU
73
n
73
LEU
73
A
THR
74
n
74
THR
74
A
ILE
75
n
75
ILE
75
A
ASP
76
n
76
ASP
76
A
GLY
77
n
77
GLY
77
A
LYS
78
n
78
LYS
78
A
THR
79
n
79
THR
79
A
ILE
80
n
80
ILE
80
A
ASN
81
n
81
ASN
81
A
VAL
82
n
82
VAL
82
A
GLU
83
n
83
GLU
83
A
PHE
84
n
84
PHE
84
A
ALA
85
n
85
ALA
85
A
LYS
86
n
86
LYS
86
A
GLY
87
n
87
GLY
87
A
SER
88
n
88
SER
88
A
author_defined_assembly
1
monomeric
gel filtration
0
0
5850
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ARG
36
A
N
ARG
36
A
O
PHE
51
A
O
PHE
51
A
O
ALA
50
A
O
ALA
50
A
N
LEU
8
A
N
LEU
8
A
N
ILE
7
A
N
ILE
7
A
O
GLU
83
A
O
GLU
83
17
A
A
HG
OE1
SER
GLU
55
58
1.56
2
A
A
ASP
THR
4
5
147.67
10
A
A
GLY
SER
87
88
145.43
15
A
A
SER
THR
15
16
144.19
20
A
A
HIS
MET
2
3
148.68
1
A
TYR
27
0.083
SIDE CHAIN
2
A
ARG
9
0.089
SIDE CHAIN
7
A
TYR
27
0.094
SIDE CHAIN
7
A
ARG
36
0.090
SIDE CHAIN
9
A
TYR
27
0.078
SIDE CHAIN
10
A
ARG
9
0.107
SIDE CHAIN
14
A
TYR
27
0.077
SIDE CHAIN
16
A
ASP
76
0.070
SIDE CHAIN
17
A
ARG
36
0.077
SIDE CHAIN
19
A
ARG
47
0.078
SIDE CHAIN
1
A
ASP
4
66.03
94.06
1
A
SER
31
-84.90
-85.56
1
A
SER
32
-170.26
-50.63
1
A
HIS
70
-46.45
152.61
1
A
ASP
76
-166.72
-22.80
1
A
ALA
85
-117.71
70.79
2
A
MET
3
74.17
30.35
2
A
THR
16
-124.85
-164.40
2
A
ALA
23
-141.30
-25.40
2
A
ALA
25
-116.48
53.85
2
A
SER
31
-85.45
37.24
2
A
SER
32
60.19
-64.01
2
A
ASP
40
-63.69
-174.77
2
A
GLN
44
65.34
-13.41
2
A
LEU
45
-65.39
-179.08
2
A
ALA
68
-153.57
-30.19
2
A
ASP
76
-170.63
24.32
3
A
HIS
2
-154.79
-64.53
3
A
ASP
4
71.65
86.31
3
A
LEU
24
-102.56
42.48
3
A
ALA
25
-119.68
54.14
3
A
TYR
27
-135.46
-59.36
3
A
ASP
76
174.67
30.25
4
A
HIS
2
-125.24
-61.54
4
A
ASP
4
46.44
83.54
4
A
THR
16
-122.66
-86.98
4
A
MET
17
-163.62
-37.30
4
A
ALA
23
-141.44
12.68
4
A
TYR
27
-137.37
-66.86
4
A
SER
32
58.21
-81.20
4
A
ALA
68
-144.16
13.90
4
A
ASP
76
-168.67
32.94
4
A
LYS
86
-101.13
69.92
5
A
MET
3
-73.46
23.24
5
A
ASP
4
-173.29
84.72
5
A
GLN
44
57.38
13.45
5
A
ASP
76
-168.54
37.07
5
A
LYS
86
-61.56
93.19
6
A
ASP
4
59.53
85.97
6
A
TYR
27
-122.09
-51.99
6
A
SER
32
61.65
-49.43
6
A
ARG
36
-66.46
86.58
6
A
GLN
42
-127.75
-51.43
6
A
ALA
68
-154.38
-14.43
6
A
LEU
69
-68.47
-162.70
6
A
ASP
76
-167.70
24.65
7
A
ASP
4
43.88
84.08
7
A
THR
16
-123.56
-57.82
7
A
MET
17
-157.71
-56.38
7
A
ILE
20
-137.38
-48.69
7
A
ALA
23
-139.95
-40.32
7
A
ALA
25
-114.68
61.90
7
A
TYR
27
-124.15
-65.01
7
A
SER
32
73.07
-56.40
7
A
ASP
40
-44.39
-86.77
7
A
LYS
41
172.41
-55.77
7
A
GLN
44
56.30
14.52
7
A
ALA
68
-139.98
-30.70
7
A
ASP
76
-174.53
34.52
8
A
ASP
4
43.03
84.03
8
A
THR
16
-107.23
-86.13
8
A
MET
17
-161.13
-68.48
8
A
SER
31
-74.05
36.47
8
A
SER
32
59.97
-73.72
8
A
LYS
41
74.55
-56.99
8
A
GLN
44
70.92
-15.15
8
A
ALA
68
-136.06
-37.82
8
A
HIS
70
-48.26
160.73
8
A
ASP
76
-174.87
34.67
8
A
ALA
85
-102.34
78.73
9
A
HIS
2
-141.77
-60.04
9
A
MET
3
53.42
-164.29
9
A
ASP
4
50.97
89.56
9
A
THR
16
-128.55
-85.87
9
A
MET
17
-156.68
-50.74
9
A
TYR
27
-142.06
-24.04
9
A
SER
32
58.18
-45.80
9
A
GLN
44
70.49
-12.73
9
A
ASP
76
173.84
17.58
10
A
MET
3
-69.52
-171.84
10
A
THR
16
-129.44
-85.83
10
A
MET
17
-158.28
-66.65
10
A
LEU
24
-86.53
30.67
10
A
ALA
25
-114.67
53.47
10
A
SER
31
-77.66
35.50
10
A
SER
32
63.63
-70.64
10
A
GLN
42
-92.72
-62.30
10
A
GLN
44
72.72
-13.77
10
A
LEU
45
-61.38
-179.07
10
A
ALA
68
-131.23
-33.01
10
A
LEU
69
-58.84
175.77
10
A
ASP
76
-171.21
32.84
11
A
MET
3
75.08
65.98
11
A
THR
16
-129.20
-86.03
11
A
MET
17
-159.45
-40.48
11
A
ALA
23
-124.38
-64.63
11
A
LEU
24
-88.77
45.53
11
A
LYS
41
75.14
-67.98
11
A
ALA
68
-147.71
-21.39
11
A
ASP
76
-164.58
29.07
11
A
LYS
86
-68.48
97.33
12
A
HIS
2
48.35
-171.82
12
A
ASP
4
45.79
94.24
12
A
THR
16
-135.83
-39.92
12
A
MET
17
-175.06
-60.08
12
A
ASP
40
-68.67
-175.48
12
A
ALA
68
-133.51
-43.32
12
A
LEU
69
-77.08
-168.89
12
A
ASP
76
178.19
42.62
12
A
LYS
86
-71.63
42.09
13
A
HIS
2
-164.00
-45.66
13
A
ASP
4
61.41
90.91
13
A
ASN
10
74.18
39.57
13
A
ASN
12
-49.53
154.60
13
A
THR
16
60.13
-164.86
13
A
ALA
23
-136.55
-37.85
13
A
LEU
24
-95.14
31.31
13
A
GLN
44
68.22
-14.31
13
A
ALA
68
-142.24
13.95
13
A
HIS
70
55.61
167.22
13
A
ASP
76
-163.70
31.04
14
A
HIS
2
74.99
-58.70
14
A
MET
3
50.94
-163.76
14
A
THR
16
-124.63
-164.24
14
A
ALA
23
-144.51
-21.62
14
A
ALA
25
-119.94
52.42
14
A
LYS
41
73.84
-20.93
14
A
GLN
44
58.73
-13.73
14
A
ASP
76
-173.01
31.07
14
A
ALA
85
-112.72
71.12
15
A
ASP
4
43.38
83.50
15
A
ILE
20
-132.32
-34.73
15
A
ALA
23
-150.65
-40.49
15
A
ALA
25
-114.54
53.67
15
A
TYR
27
-124.41
-79.60
15
A
SER
31
-79.63
23.45
15
A
SER
32
55.29
-60.41
15
A
GLN
42
-124.08
-50.56
15
A
GLN
44
71.74
-12.66
15
A
ASN
46
-69.63
-165.73
15
A
ALA
68
-131.40
-34.42
15
A
LEU
69
-75.84
-166.77
15
A
ILE
75
-145.44
13.98
15
A
ASP
76
-166.70
18.58
16
A
ASP
4
74.73
98.32
16
A
THR
16
-125.64
-74.17
16
A
MET
17
-153.80
-48.00
16
A
ALA
23
-143.16
-34.20
16
A
ALA
25
-115.71
53.47
16
A
GLN
42
-130.35
-42.29
16
A
GLN
44
73.11
-13.73
16
A
LEU
54
-135.89
-154.86
16
A
ASP
76
-173.94
28.00
17
A
ASP
4
75.25
94.53
17
A
ALA
23
-142.60
12.98
17
A
ALA
25
-114.95
52.66
17
A
TYR
27
-134.59
-58.12
17
A
SER
31
-90.18
33.00
17
A
SER
32
68.61
-61.95
17
A
GLN
44
57.32
14.77
17
A
ALA
68
-141.65
14.50
17
A
ASP
76
-171.68
41.07
18
A
MET
3
-151.37
82.88
18
A
ASP
4
174.78
109.00
18
A
THR
16
-147.29
-74.69
18
A
MET
17
-160.67
-57.22
18
A
ILE
20
-135.11
-47.09
18
A
SER
32
174.92
-46.59
18
A
HIS
70
49.75
166.93
18
A
ASP
76
-166.82
31.21
19
A
HIS
2
-130.22
-72.47
19
A
MET
3
-167.24
93.07
19
A
ASP
4
42.63
83.23
19
A
ALA
23
-149.28
-34.98
19
A
ALA
25
-116.87
57.06
19
A
GLN
44
66.14
-13.30
19
A
LEU
45
-65.11
-167.53
19
A
ASP
76
-169.32
33.82
20
A
HIS
2
55.05
170.81
20
A
ASP
4
57.99
84.68
20
A
THR
16
44.45
-164.59
20
A
GLN
44
72.32
-13.06
20
A
ALA
68
-144.06
14.47
20
A
HIS
70
-46.66
158.47
20
A
ASP
76
-161.39
37.74
N
RBM10-RRM2 domain and its lung cancer related mutant
1
N
N
A
MET
17
A
MET
17
HELX_P
A
GLY
22
A
GLY
22
1
AA1
6
A
SER
55
A
SER
55
HELX_P
A
GLN
67
A
GLN
67
1
AA2
13
RNA BINDING PROTEIN
classical folding and binding mode, RNA BINDING PROTEIN
RBM10_HUMAN
UNP
1
223
P98175
P98175-4
DTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTINVE
FAKGS
223
307
5ZSY
4
88
P98175
A
1
4
88
1
expression tag
GLY
1
5ZSY
A
P98175
UNP
1
1
expression tag
HIS
2
5ZSY
A
P98175
UNP
2
1
expression tag
MET
3
5ZSY
A
P98175
UNP
3
4
anti-parallel
anti-parallel
anti-parallel
A
VAL
35
A
VAL
35
A
ARG
36
A
ARG
36
A
ALA
50
A
ALA
50
A
ILE
52
A
ILE
52
A
ILE
6
A
ILE
6
A
ARG
9
A
ARG
9
A
ASN
81
A
ASN
81
A
PHE
84
A
PHE
84